- Home
- CDXS vs MVBF Comparison
CDXS vs MVBF Comparison
Compare CDXS & MVBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- MVBF
- Stock Information
- Founded
- CDXS 2002
- MVBF 1997
- Country
- CDXS United States
- MVBF United States
- Employees
- CDXS N/A
- MVBF N/A
- Industry
- CDXS Major Chemicals
- MVBF Major Banks
- Sector
- CDXS Industrials
- MVBF Finance
- Exchange
- CDXS Nasdaq
- MVBF Nasdaq
- Market Cap
- CDXS 176.4M
- MVBF 205.7M
- IPO Year
- CDXS 2010
- MVBF N/A
- Fundamental
- Price
- CDXS $2.46
- MVBF $17.94
- Analyst Decision
- CDXS Buy
- MVBF Buy
- Analyst Count
- CDXS 2
- MVBF 3
- Target Price
- CDXS $11.00
- MVBF $24.67
- AVG Volume (30 Days)
- CDXS 500.7K
- MVBF 23.2K
- Earning Date
- CDXS 05-14-2025
- MVBF 04-30-2025
- Dividend Yield
- CDXS N/A
- MVBF 3.79%
- EPS Growth
- CDXS N/A
- MVBF N/A
- EPS
- CDXS N/A
- MVBF 1.46
- Revenue
- CDXS $59,345,000.00
- MVBF $146,101,000.00
- Revenue This Year
- CDXS $12.62
- MVBF N/A
- Revenue Next Year
- CDXS $22.11
- MVBF $14.09
- P/E Ratio
- CDXS N/A
- MVBF $12.30
- Revenue Growth
- CDXS N/A
- MVBF N/A
- 52 Week Low
- CDXS $1.90
- MVBF $15.59
- 52 Week High
- CDXS $6.08
- MVBF $25.24
- Technical
- Relative Strength Index (RSI)
- CDXS 51.79
- MVBF 63.58
- Support Level
- CDXS $2.23
- MVBF $17.13
- Resistance Level
- CDXS $2.59
- MVBF $18.20
- Average True Range (ATR)
- CDXS 0.14
- MVBF 0.68
- MACD
- CDXS 0.05
- MVBF 0.18
- Stochastic Oscillator
- CDXS 70.45
- MVBF 88.05
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About MVBF MVB Financial Corp.
MVB Financial Corp is a bank holding company. The company provides Personal banking, Business banking, and Fintech solutions. The group has identified three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of ts revenue generated from the CoRe Banking segment, which includes the Fintech division, represents banking products and services offered to customers by the Bank, loans, and deposit accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.